Headquartered in San Francisco, California, McKesson Corporation (NYSE:MCK) is a global provider of healthcare supply chain management solutions, retail pharmacy, community oncology cum specialty care, and healthcare information technology.
Currently, McKesson has a Zacks Rank #3 (Hold) but that could change following its second quarter fiscal 2018 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.) We have highlighted some of the key details from the just-released announcement below:
Earnings: McKesson’s adjusted earnings of $3.28 per share came above the Zacks Consensus Estimate of $2.78 and increased from $2.96 in the year-ago quarter.
Revenues: McKesson posted sales of $52.1 billion, beating the Zacks Consensus Estimate for revenues of $51.6 billion. This was up from $50.0 billion last year.
Key Stats: Distribution Solutions sales increased 5% at cc, while Technology Solutions decreased 82% from the year-ago quarter.
McKesson Corporation Price and EPS Surprise
McKesson Corporation Price and EPS Surprise | McKesson Corporation Quote
Major Factors: Performance improved due to higher profits owing to market growth and acquisitions. Lower profit in Technology Solutions segment was driven primarily by the contribution of the majority of the businesses to Change Healthcare JV.
McKesson expects GAAP earnings per diluted share between $4.80 to $6.90 for the fiscal year ending Mar 31, 2018. Adjusted Earnings for the same are expected in the range of $11.80 to $12.50 per diluted share.
Check back later for our full write up on this McKesson report later!
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
McKesson Corporation (MCK): Free Stock Analysis Report
Original post
Zacks Investment Research